amotosalen has been researched along with Thrombopenia in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (60.00) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Anani, W; Bailey, SL; Benjamin, RJ; Cancelas, JA; Corash, L; Dumont, LJ; Erickson, AC; Genthe, JR; Mack, S; Mufti, N; Nestheide, S; Rugg, N; Schroeder, K; Shaz, B; Stolla, M; Szczepiorkowski, ZM; Yegneswaran, S | 1 |
| Benjamin, RJ; Bringmann, PW; Fadeyi, EA; Goldberg, C; Lu, T; Meier, NM; Namen, AM; Palavecino, E; Wagner, SJ; Young, P | 1 |
| Doree, C; Estcourt, LJ; Hopewell, S; Malouf, R; Murphy, MF; Stanworth, SJ; Trivella, M | 1 |
| Compernolle, V; Feys, HB; Van Aelst, B | 1 |
| Gemdzhian, ÉG; Gorodetskiĭ, VM; Grachev, AE; Kastrikina, IS; Krechetova, AV; Nakastoev, IM; Ryzhko, VV; Tsyba, NN; Vatagina, EA; Zhuravlev, VV | 1 |
| Brand, A; de Greef, GE; Huijgens, PC; Kerkhoffs, JL; Luten, M; Novotny, VM; Schipperus, MR; Te Boekhorst, PA; van Pampus, LC; van Putten, WL; van Rhenen, DJ; Zwaginga, JJ | 1 |
| Buchholz, D; Cazenave, JP; Conlan, M; Corash, L; Davis, K; de Greef, G; Flament, J; Gulliksson, H; Kappers-Klunne, M; Klüter, H; Laforet, M; Lin, L; Lioure, B; Ljungman, P; Marblie, S; Mayaudon, V; Metzel, P; Pamphilon, D; van Rhenen, D; Vermeij, H | 1 |
| Benjamin, RJ; Buchholz, DH; Cable, R; Conlan, MG; Corash, L; Coutre, S; Davis, K; Fridey, JL; Goodnough, LT; Howard, F; Koutsoukos, A; Lin, JS; Lin, L; Lopez-Plaza, I; McCullough, J; Metzel, P; Murphy, S; Pineda, A; Raife, T; Slichter, SJ; Snyder, E; Stadtmauer, EA; Strauss, RG; Vesole, DH | 1 |
| Beris, P; Cazenave, JP; Conlan, MG; Flament, J; Hastka, J; Janetzko, K; Kientz, D; Klüter, H; Lin, JS; Lin, L; Lioure, B; Marblie, S; Mayaudon, V; Michel, M | 1 |
| Cimino, G; Conlan, MG; Lin, L; Porter, S; Tessman, J | 1 |
| Conlan, MG; Corash, L; Lin, JS; Lopez-Plaza, I; McCullough, J; Slichter, SJ; Snyder, E; Strauss, RG | 1 |
| Cable, R; Conlan, MG; Corash, L; Lin, JS; McCullough, J; Murphy, S; Slichter, SJ; Snyder, E; Strauss, RG | 1 |
| Borregaard, N; Conlan, MG; Flament, J; Jacquet, M; Johansson, PI; Junge, K; Lin, JS; Lin, L; Simonsen, AC; Sørensen, H | 1 |
| Sandler, SG | 1 |
| Buchholz, DH; Conlan, MG; Corash, L; Davis, K; Raife, TJ; Rheinschmidt, M; Slichter, SJ | 1 |
3 review(s) available for amotosalen and Thrombopenia
| Article | Year |
|---|---|
Pathogen-reduced platelets for the prevention of bleeding.
Topics: Adult; Antisepsis; Blood Platelets; Child; Disease Transmission, Infectious; Furocoumarins; Hemorrhage; Humans; Photosensitizing Agents; Platelet Transfusion; Randomized Controlled Trials as Topic; Riboflavin; Thrombocytopenia; Ultraviolet Rays | 2017 |
Biomolecular Consequences of Platelet Pathogen Inactivation Methods.
Topics: Blood Banks; Blood Platelets; Blood Preservation; Blood Transfusion; Furocoumarins; Hemostasis; Humans; Neoplasms; Nucleic Acids; Platelet Transfusion; Riboflavin; Signal Transduction; Thrombocytopenia; Ultraviolet Rays | 2019 |
Amotosalen interactions with platelet and plasma components: absence of neoantigen formation after photochemical treatment.
Topics: Antilymphocyte Serum; Blood Coagulation Disorders; Blood Platelets; Blood Proteins; Blood Transfusion; Cell Membrane; Chromatography, High Pressure Liquid; Clinical Trials, Phase III as Topic; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Furocoumarins; Humans; Isoantibodies; Isoantigens; Photochemistry; Plasma; Platelet Transfusion; Randomized Controlled Trials as Topic; Solubility; Thrombocytopenia; Ultraviolet Rays; Virus Inactivation | 2005 |
10 trial(s) available for amotosalen and Thrombopenia
| Article | Year |
|---|---|
[Clinical efficiency of transfusion of pathogen-inactivated platelet concentrates].
Topics: Adult; Female; Furocoumarins; Humans; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Platelet Transfusion; Prospective Studies; Thrombocytopenia; Treatment Outcome; Young Adult | 2013 |
Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction.
Topics: Adult; Aged; Bacterial Infections; Blood Platelets; Blood Preservation; Female; Furocoumarins; Hemorrhage; Humans; Leukocyte Reduction Procedures; Male; Middle Aged; Plasma; Platelet Transfusion; Thrombocytopenia; Treatment Outcome; Ultraviolet Rays; Virus Diseases | 2010 |
Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial.
Topics: Adult; Bacterial Infections; Blood Group Incompatibility; Blood Preservation; Double-Blind Method; Erythrocyte Transfusion; Female; Furocoumarins; Hemorrhage; Hemostasis; Humans; Male; Middle Aged; Photochemistry; Photosensitizing Agents; Platelet Count; Platelet Transfusion; Specimen Handling; Thrombocytopenia; Time Factors; Ultraviolet Rays; Virus Diseases | 2003 |
Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Platelets; Blood-Borne Pathogens; Child; Erythrocyte Transfusion; Female; Furocoumarins; Hemorrhage; Humans; Male; Middle Aged; Photochemistry; Platelet Transfusion; Prospective Studies; Thrombocytopenia | 2004 |
Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set.
Topics: Adult; Aged; Antibodies; Bacterial Infections; Blood Component Removal; Erythrocyte Transfusion; Female; Furocoumarins; Hemorrhage; Humans; Male; Middle Aged; Photochemistry; Platelet Count; Platelet Transfusion; Thrombocytopenia; Ultraviolet Rays | 2005 |
Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial.
Topics: Adult; Bacteria; Bacterial Infections; Blood Banking; Blood Banks; Cause of Death; Female; Furocoumarins; Hemorrhage; Humans; Incidence; Male; Middle Aged; Platelet Transfusion; Plateletpheresis; Safety; Skin Diseases; Thrombocytopenia; Thrombosis; Ultraviolet Rays | 2005 |
Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light.
Topics: Adult; Female; Furocoumarins; Hemorrhage; Humans; Male; Middle Aged; Platelet Transfusion; Thrombocytopenia; Ultraviolet Therapy | 2006 |
Transfusion of 7-day-old amotosalen photochemically treated buffy-coat platelets to patients with thrombocytopenia: a pilot study.
Topics: Adolescent; Adult; Blood Preservation; Female; Furocoumarins; Hemostasis; Humans; Male; Microbial Viability; Pilot Projects; Platelet Transfusion; PUVA Therapy; Thrombocytopenia; Time Factors | 2006 |
Treating thrombocytopenia with pathogen-reduced platelets.
Topics: Blood Platelets; Furocoumarins; Hemorrhage; Humans; Microbial Viability; Platelet Count; Platelet Transfusion; Plateletpheresis; Thrombocytopenia; Ultraviolet Rays | 2006 |
Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia.
Topics: Adolescent; Adult; Bleeding Time; Blood Platelets; Bone Marrow Transplantation; Furocoumarins; Hematologic Neoplasms; Hemorrhage; Hemostasis; Humans; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Photosensitizing Agents; Platelet Transfusion; Plateletpheresis; Thrombocytopenia; Time Factors; Ultraviolet Rays | 2006 |
2 other study(ies) available for amotosalen and Thrombopenia
| Article | Year |
|---|---|
Evaluation of amotosalen and UVA pathogen-reduced apheresis platelets after 7-day storage.
Topics: Blood Platelets; Blood Preservation; Furocoumarins; Humans; Platelet Transfusion; Plateletpheresis; Thrombin; Thrombocytopenia; Transfusion Reaction; Ultraviolet Rays | 2022 |
Fatal sepsis associated with a storage container leak permitting platelet contamination with environmental bacteria after pathogen reduction.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Blood Platelets; Blood-Borne Pathogens; Coinfection; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Equipment Contamination; Equipment Failure; Fatal Outcome; Furocoumarins; Hip Fractures; Humans; Male; Middle Aged; Platelet Transfusion; Sepsis; Staphylococcal Infections; Staphylococcus saprophyticus; Thrombocytopenia; Transfusion Reaction; Ultraviolet Rays | 2021 |